Re: TASHA - Advancing Remote Patient Monitoring for Diabetic Foot Ulcers: A Patient-Centered Approach application

回复：TASHA - 推进糖尿病足溃疡的远程患者监测：以患者为中心的方法应用

• 批准号: 10089130
• 金额: $ 9.9万
• 依托单位: MEDICAL INTELLIGENCE GROUP LTD
• 依托单位国家: 英国
• 项目类别: Collaborative R&D
• 财政年份: 2023
• 资助国家: 英国
• 起止时间: 2023 至 无数据
• 项目状态: 未结题
• 来源: https://gtr.ukri.org/projects?ref=10089130
• 关键词: Re; TASHA; Advancing; Remote; Patient

Diabetes, the 9th leading cause of death globally and a significant co-morbidity to cardiac-related deaths, poses a major health concern. In the UK alone, over 4 million individuals diagnosed with diabetes face a staggering 23-fold increased risk of developing diabetic foot ulcers (DFUs). Alarmingly, 10% of these DFUs lead to foot amputations, with a mortality rate of 50% within two years. Globally, there are over 450 million diabetics, projected to grow to 578 million by 2030\.To address this urgent issue, Medical Intelligence Group (MIG) offers an innovative three-pillar solution that utilises novel digital and data-enabled tools to more accurately diagnose conditions, stratify patients to appropriate treatments, and increase the application of integrated and multi-modal approaches to determine risk, diagnosis, and predict prognostic outcomes.MIG's solution includes remote monitoring technology, early ulcer detection systems, and AI predictive modelling. By improving ulcer monitoring and enabling timely treatments, MIG's solution significantly improves patient outcomes, relieves stress, and generates cost savings for the NHS. Additionally, the early detection of deteriorating ulcers reduces the need for amputations, benefiting patients both socially and economically.MIG's innovative approach fills an unmet clinical need and addresses the pressing challenge of diabetic foot ulcers. By leveraging novel digital tools, MIG aims to make substantial progress in combating this condition, improving patient well-being, and alleviating the healthcare burden.

糖尿病是全球第九大死亡原因，也是与心脏相关的死亡的重要共同发病率，是一个主要的健康问题。仅在英国，超过400万被诊断为糖尿病的人患糖尿病足部溃疡(DFU)的风险增加了23倍，令人震惊。令人震惊的是，这些DFU中有10%会导致足部截肢，两年内的死亡率为50%。全球有超过4.5亿的糖尿病患者，预计到2030年将增长到5.78亿。为了解决这一紧迫问题，医疗情报集团(MIG)提供了一个创新的三支柱解决方案，利用新的数字和数据启用工具来更准确地诊断病情，对患者进行适当的治疗，并增加综合和多模式方法的应用，以确定风险、诊断和预测预后结果。MIG的解决方案包括远程监控技术、早期溃疡检测系统和AI预测建模。通过改进溃疡监测和及时治疗，MIG的解决方案显著改善了患者的预后，缓解了压力，并为NHS节省了成本。此外，早期发现恶化的溃疡减少了截肢的需要，使患者在社会和经济上受益。MIG的创新方法填补了未得到满足的临床需求，并解决了糖尿病足部溃疡的紧迫挑战。通过利用新的数字工具，MIG的目标是在抗击这种疾病、改善患者福祉和减轻医疗负担方面取得实质性进展。